Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-11-000833
Filing Date
2011-08-22
Accepted
2011-08-22 14:32:56
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vg10q-june302011.htm 10-Q 758093
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER ex31-1.htm EX-31 20646
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER ex31-2.htm EX-31 20985
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS ex32.htm EX-32 11262
  Complete submission text file 0001415889-11-000833.txt   3442624

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vsta-20110630.xml EX-101.INS 543192
6 XBRL TAXONOMY EXTENSION SCHEMA vsta-20110630.xsd EX-101.SCH 18894
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsta-20110630_cal.xml EX-101.CAL 49852
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsta-20110630_def.xml EX-101.DEF 104552
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsta-20110630_lab.xml EX-101.LAB 162866
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsta-20110630_pre.xml EX-101.PRE 111314
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 111049558
SIC: 2834 Pharmaceutical Preparations